Robert Gensure

A mutant PTH/PTHrP type I receptor in enchondromatosis.

Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.

Identification and characterization of two parathyroid hormone-like molecules in zebrafish.

Haplotype frequencies and linkage disequilibrium analysis of four frequent polymorphisms at the PTH/PTH-related peptide receptor gene locus.

Identification and characterization of the zebrafish and fugu genes encoding tuberoinfundibular peptide 39.

Parathyroid hormone without parathyroid glands.

Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS.

A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%.

Ca2+-induced linker transformation leads to a compact and rigid collagen-binding domain of Clostridium histolyticum collagenase.

A new technique for precisely and accurately measuring lumbar spine bone mineral density in mice using clinical dual energy X-ray absorptiometry (DXA).

A treatment trial of vitamin D supplementation in breast-fed infants: universal supplementation is not necessary for rickets prevention in Southern Louisiana.

Effects of stress after hurricanes katrina and rita on pubertal disorders in children.

Breast-feeding and Vitamin D Supplementation Rates in the Ochsner Health System.

Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.

Reversed seasonal variation in maternal vitamin D levels in southern Louisiana.

A single injection of the anabolic bone agent, parathyroid hormone-collagen binding domain (PTH-CBD), results in sustained increases in bone mineral density for up to 12 months in normal female mice.

Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.

Clinical response to combined therapy of cyclosporine and prednisone.

Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain.

Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct.

Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.

Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?